Bain and Cinven revisit IPO for Stada
Bain Capital and Cinven are resuming IPO preparations for German pharmaceutical company Stada Arzneimittel, following a pause in sale discussions with CapVest Partners, according to a report by Bloomberg citing sources familiar with the matter.

